PGF concentration in the medium after 24 hours of co-culture for all treatments for endometrial samples from pregnant (P+) and non-pregnant (NP) mares. by K. M. Klohonatz (6425279)

Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs. by Yang Zhang (30734)

FAK and p-FAK expression and protein abundance for all treatments in endometrial samples from pregnant (P+) and non-pregnant (NP) mares. by K. M. Klohonatz (6425279)

Gene and protein abundance for β-integrins for all treatments in endometrial samples from pregnant (P+) and non-pregnant (NP) mares. by K. M. Klohonatz (6425279)

Actin genes and protein abundance for all treatments in endometrial samples from pregnant (P+) and non-pregnant (NP) mares. by K. M. Klohonatz (6425279)

Gene abundance for α-integrins for all treatments in endometrial samples from pregnant (P+) and non-pregnant (NP) mares. by K. M. Klohonatz (6425279)

Comparison of the amount of locomotor activity (mean counts per day) and the night-day ratio in control and diabetic animals submitted to two light schedules. by Hasna Lahouaoui (595100)

“…(B) In the second light schedule, animals were submitted to successive decreases in light intensity. These SZT-diabetic mice exhibited a reduction in their total locomotor activity at the three light intensities (at 1000 lux: controls: 2099.5±122.1 counts; STZ-diabetic: 1704.7±125.9 counts; p≤0.01; at 300 lux: controls: 2658.7±112.9 counts; STZ-diabetic: 2124.4±0.1 counts; p≤0.001 and at 100 lux: controls: 2864.7±58.4 counts; STZ-diabetic: 2508.7±47.5 counts; p≤0.05), with a significant decreased ratio of night-day activity at 300 lux and 100 lux. …”

A sample logarithmic model of vascular calibre determination in which the vessel diameter is logarithmically dependent on the local haemodynamic factors (B) or the metabolic stimul... by Jessica R. Crawshaw (12564991)

Proteomic analysis of control, TGF-β1 model, and melatonin-treated HBdSMCs. by Yang Zhang (30734)

Study design and bodyweight evolution. by Rodrick Montjean (400649)

Gene and protein abundance for Bcl-2, CAV1, CCND1 and PAK6 for all treatments in endometrial samples from pregnant (P+) and non-pregnant (NP) mares. by K. M. Klohonatz (6425279)

Migration capacity of HPAEC and CTEPH-EC in basal and with HSP70 inhibitor VER-155008. by William Salibe-Filho (9727738)

Electrocardiographic parameters in NTG, Gα_q-TG, and Gα_q-TG+olmesartan mice. by Naoko Matsushita (113751)

Echocardiographic parameters in NTG, Gα_q-TG, and Gα_q-TG+olmesartan mice. by Naoko Matsushita (113751)

Effects of olmesartan on protein expression of angiotensin converting enzyme (ACE) isoforms and angiotensin II type 1 (AT₁) receptor. by Naoko Matsushita (113751)

LM11A-31 prevents dystrophy of cholinergic neurites in mid- to late-stage female Tg2576 mice. by Danielle A. Simmons (621167)

“…<p>Quantitative analysis showed that treating female Tg2576 mice starting at 14 months of age with LM11A-31 for 3 months prevented and/or reversed the decreases in (<b><i>A</i></b>) length, (<b><i>B</i></b>) surface area, and (<b><i>C</i></b>) branching of BFCN neurites. …”

<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate.... by Atefeh Sadeghi (21253051)

“…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”

Protein expression and specific activity of Glo-I in whole liver and specific activity of Glo-I in pHEP, pHSC and pLSEC in controls, early and advanced cirrhosis. by Marcus Hollenbach (376231)

General parameters and the incidence of premature ventricular contraction (PVC) in NTG, Gα_q-TG, and Gα_q-TG+olmesartan mice. by Naoko Matsushita (113751)

Mean global migration change due to the climate change impact, for each SSP scenario, climate change impact method and emigration rates assumption. by Albano Rikani (14129046)

“…For each case we show separately the total (net) change of migration, the change in the total flows that increased and in those that decreased. The error bars represent the extremes reached within the ensemble of GCMs that we use, while the bars show the mean value reached within the set of GCMs. …”